Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tenofovir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021 4 3
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 92 22
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
Raltegravir Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/06/2020 5 0
Stavudine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/06/2020 2 0
RBD-12GS-I53-50 Potential treatment - pre-clinical evidence Experimental Vaccine Oct/30/2020 1 0
RBD-16GS-I53-50 Potential treatment - pre-clinical evidence Experimental Vaccine Oct/30/2020 1 0